179 related articles for article (PubMed ID: 35393124)
21. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
22. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?
Chun YS; Lindor NM; Smyrk TC; Petersen BT; Burgart LJ; Guilford PJ; Donohue JH
Cancer; 2001 Jul; 92(1):181-7. PubMed ID: 11443625
[TBL] [Abstract][Full Text] [Related]
23. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
Graziano F; Humar B; Guilford P
Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.
Bardram L; Hansen TV; Gerdes AM; Timshel S; Friis-Hansen L; Federspiel B
Fam Cancer; 2014 Jun; 13(2):231-42. PubMed ID: 24389957
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer.
Francis WP; Rodrigues DM; Perez NE; Lonardo F; Weaver D; Webber JD
JSLS; 2007; 11(1):142-7. PubMed ID: 17651578
[TBL] [Abstract][Full Text] [Related]
26. CDH1 mutations recurrence and global clustering in genetically tested families with hereditary diffuse gastric cancer syndrome: results from a systematic study.
Corso G; Tagliaferri V; Massari G; Cioffi A; Rossi EMC; Veronesi P; Magnoni F
Fam Cancer; 2023 Apr; 22(2):187-192. PubMed ID: 35882702
[TBL] [Abstract][Full Text] [Related]
27. Hereditary diffuse gastric cancer - pathophysiology and clinical management.
Pinheiro H; Oliveira C; Seruca R; Carneiro F
Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1055-68. PubMed ID: 25439071
[TBL] [Abstract][Full Text] [Related]
28. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
Black MD; Kaneshiro R; Lai JI; Shimizu DM
Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
30. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
[TBL] [Abstract][Full Text] [Related]
31. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
[TBL] [Abstract][Full Text] [Related]
32. Pregnancy after prophylactic total gastrectomy.
Kaurah P; Fitzgerald R; Dwerryhouse S; Huntsman DG
Fam Cancer; 2010 Sep; 9(3):331-4. PubMed ID: 20063069
[TBL] [Abstract][Full Text] [Related]
33. CDH1 associated gastric cancer: a report of a family and review of the literature.
Moran CJ; Joyce M; McAnena OJ
Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
[TBL] [Abstract][Full Text] [Related]
34. Controversies and strengths in prophylactic total gastrectomy for germline CDH1 pathogenic variant carriers.
Davis JL; Strong VE
Eur J Cancer Prev; 2023 Jul; 32(4):308-309. PubMed ID: 37038999
[No Abstract] [Full Text] [Related]
35. Prophylactic total gastrectomy for individuals with germline CDH1 mutation.
Pandalai PK; Lauwers GY; Chung DC; Patel D; Yoon SS
Surgery; 2011 Mar; 149(3):347-55. PubMed ID: 20719348
[TBL] [Abstract][Full Text] [Related]
36. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
Guilford P; Humar B; Blair V
Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
[TBL] [Abstract][Full Text] [Related]
39. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
[TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]